Citadel Advisors - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is and the CUSIP is 68827R908. A total of 2 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2016$61,000
-48.7%
11,900
-42.8%
0.00%
Q1 2016$119,000
-4.8%
20,800
+73.3%
0.00%
Q4 2015$125,000
-13.2%
12,000
+53.8%
0.00%
Q3 2015$144,000
-53.1%
7,800
-50.6%
0.00%
Q2 2015$307,000
+44.1%
15,800
+30.6%
0.00%
Q1 2015$213,000
+217.9%
12,100
+188.1%
0.00%
Q4 2014$67,000
+346.7%
4,200
+250.0%
0.00%
Q3 2014$15,000
-70.0%
1,200
-62.5%
0.00%
Q2 2014$50,000
-25.4%
3,200
-37.3%
0.00%
Q1 2014$67,000
-46.4%
5,100
-34.6%
0.00%
Q4 2013$125,000
-20.9%
7,800
-17.9%
0.00%
Q3 2013$158,000
+182.1%
9,500
+69.6%
0.00%
Q2 2013$56,0005,6000.00%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 65,900$1,060,0000.02%
Citadel Advisors 7,800$125,0000.00%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders